BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nebbioso M, Lambiase A, Cerini A, Limoli PG, La Cava M, Greco A. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules. Int J Mol Sci 2019;20:E1693. [PMID: 30987401 DOI: 10.3390/ijms20071693] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Potilinski MC, Tate PS, Lorenc VE, Gallo JE. New insights into oxidative stress and immune mechanisms involved in age-related macular degeneration tackled by novel therapies. Neuropharmacology 2021;188:108513. [PMID: 33662390 DOI: 10.1016/j.neuropharm.2021.108513] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Ferrington DA, Fisher CR, Kowluru RA. Mitochondrial Defects Drive Degenerative Retinal Diseases. Trends Mol Med 2020;26:105-18. [PMID: 31771932 DOI: 10.1016/j.molmed.2019.10.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
3 Jiang D, Chen FX, Zhou H, Lu YY, Tan H, Yu SJ, Yuan J, Liu H, Meng W, Jin ZB. Bioenergetic Crosstalk between Mesenchymal Stem Cells and various Ocular Cells through the intercellular trafficking of Mitochondria. Theranostics 2020;10:7260-72. [PMID: 32641991 DOI: 10.7150/thno.46332] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 32.0] [Reference Citation Analysis]
4 Keenan TDL, Oden NL, Agrón E, Clemons TE, Henning A, Fritsche LG, Wong WT, Chew EY; AREDS2 Research Group. Cluster analysis and genotype-phenotype assessment of geographic atrophy in age-related macular degeneration: AREDS2 Report 25. Ophthalmol Retina 2021:S2468-6530(21)00229-3. [PMID: 34325054 DOI: 10.1016/j.oret.2021.07.006] [Reference Citation Analysis]
5 Barratt J, Weitz I. Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway. Front Immunol 2021;12:712572. [PMID: 34566967 DOI: 10.3389/fimmu.2021.712572] [Reference Citation Analysis]
6 Tan W, Zou J, Yoshida S, Jiang B, Zhou Y. The Role of Inflammation in Age-Related Macular Degeneration. Int J Biol Sci 2020;16:2989-3001. [PMID: 33061811 DOI: 10.7150/ijbs.49890] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
7 Ma HH, Liutkevičienė R. Age-Related Macular Degeneration: What Do We Know So Far? Acta Med Litu 2021;28:36-47. [PMID: 34393627 DOI: 10.15388/Amed.2021.28.1.7] [Reference Citation Analysis]
8 Wu Z, Pfau M, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Staurenghi G, Bjelopera E, Brown T, Chang P, Choong J, Corradetti G, Corvi F, Domalpally A, Hurtenbach C, Nittala MG, Olson A, Pak JW, Pappe J, Saßmannshausen M, Skalak C, Thiele S, Guymer RH, Schmitz-Valckenberg S. OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6. Ophthalmol Retina 2021:S2468-6530(21)00093-2. [PMID: 33766801 DOI: 10.1016/j.oret.2021.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
9 Alfaleh MA, Alsaab HO, Mahmoud AB, Alkayyal AA, Jones ML, Mahler SM, Hashem AM. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Front Immunol 2020;11:1986. [PMID: 32983137 DOI: 10.3389/fimmu.2020.01986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
10 Ort M, Dingemanse J, van den Anker J, Kaufmann P. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Front Immunol 2020;11:599417. [PMID: 33362783 DOI: 10.3389/fimmu.2020.599417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Veritti D, Sarao V, Samassa F, Danese C, Löwenstein A, Schmidt-Erfurth U, Lanzetta P. State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration. Expert Opin Pharmacother 2020;21:773-84. [PMID: 32153203 DOI: 10.1080/14656566.2020.1736557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Othman R, Berbari S, Vaucher E, Couture R. Differential Expression of Kinin Receptors in Human Wet and Dry Age-Related Macular Degeneration Retinae. Pharmaceuticals (Basel) 2020;13:E130. [PMID: 32599742 DOI: 10.3390/ph13060130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sarda SP, Heyes A, Bektas M, Thakur T, Chao W, Intorcia M, Wronski S, Jones DL. Humanistic and Economic Burden of Geographic Atrophy: A Systematic Literature Review. Clin Ophthalmol 2021;15:4629-44. [PMID: 34916775 DOI: 10.2147/OPTH.S338253] [Reference Citation Analysis]
14 Kim MH, Kim DH, Yang SG, Kim DY. Improved effect of a mitochondria-targeted antioxidant on hydrogen peroxide-induced oxidative stress in human retinal pigment epithelium cells. BMC Pharmacol Toxicol 2021;22:7. [PMID: 33472699 DOI: 10.1186/s40360-020-00471-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Chen X, Zuo J, Hu T, Shi X, Zhu Y, Wu H, Xia Y, Shi W, Wei W. Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification. Drug Des Devel Ther 2021;15:2831-42. [PMID: 34234414 DOI: 10.2147/DDDT.S310481] [Reference Citation Analysis]
16 Gocuk SA, Mckendrick AM, Downie LE. Point‐of‐care tools to support optometric care provision to people with age‐related macular degeneration: A randomised, placebo‐controlled trial. Ophthalmic Physiologic Optic. [DOI: 10.1111/opo.12970] [Reference Citation Analysis]
17 Jordan SC, Kucher K, Bagger M, Hockey H, Wagner K, Ammerman N, Vo A. Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti‐C5 monoclonal antibody tesidolumab. Am J Transplant 2020;20:2581-8. [DOI: 10.1111/ajt.15922] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
18 Bhatwadekar AD, Kansara V, Luo Q, Ciulla T. Anti-integrin therapy for retinovascular diseases. Expert Opin Investig Drugs 2020;29:935-45. [PMID: 32657172 DOI: 10.1080/13543784.2020.1795639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kim MH, Kwon SY, Woo SY, Seo WD, Kim DY. Antioxidative Effects of Chrysoeriol via Activation of the Nrf2 Signaling Pathway and Modulation of Mitochondrial Function. Molecules 2021;26:E313. [PMID: 33435366 DOI: 10.3390/molecules26020313] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Borucki DM, Toutonji A, Couch C, Mallah K, Rohrer B, Tomlinson S. Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System. Front Immunol 2020;11:566892. [PMID: 33072106 DOI: 10.3389/fimmu.2020.566892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Gocuk SA, Lee J, Keller PR, Ayton LN, Guymer RH, Mckendrick AM, Downie LE. Clinical audit as an educative tool for optometrists: an intervention study in age‐related macular degeneration. Ophthalmic Physiol Opt 2021;41:53-72. [DOI: 10.1111/opo.12754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Patil MA, Kompella UB. Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning. J Ocul Pharmacol Ther 2020;36:458-66. [PMID: 32552217 DOI: 10.1089/jop.2020.0028] [Reference Citation Analysis]
23 Puliafito CA, Wykoff CC. Looking ahead in retinal disease management: highlights of the 2019 angiogenesis, exudation and degeneration symposium. Int J Retina Vitreous 2019;5:22. [PMID: 31161069 DOI: 10.1186/s40942-019-0174-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Wu J, Sun X. Complement system and age-related macular degeneration: drugs and challenges. Drug Des Devel Ther 2019;13:2413-25. [PMID: 31409975 DOI: 10.2147/DDDT.S206355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]